Cargando…
Milk immunoglobulins for health promotion
The biological function of bovine colostral immunoglobulins is to provide the newborn calf with adequate passive immune protection against microbial infections. Immunoglobulin preparations designed for farm animals are commercially available, and some colostrum-based products are marketed also for h...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135675/ https://www.ncbi.nlm.nih.gov/pubmed/32288340 http://dx.doi.org/10.1016/j.idairyj.2006.06.003 |
_version_ | 1783518109907288064 |
---|---|
author | Mehra, Raj Marnila, Pertti Korhonen, Hannu |
author_facet | Mehra, Raj Marnila, Pertti Korhonen, Hannu |
author_sort | Mehra, Raj |
collection | PubMed |
description | The biological function of bovine colostral immunoglobulins is to provide the newborn calf with adequate passive immune protection against microbial infections. Immunoglobulin preparations designed for farm animals are commercially available, and some colostrum-based products are marketed also for humans as dietary supplements. The concentration of specific antibodies against a certain pathogenic microorganism can be raised in colostrum and milk by immunizing cows with this pathogen or its antigen. Advances in bioseparation and chromatographic techniques have made it possible to fractionate and enrich these antibodies and formulate so-called hyperimmune colostral or milk preparations. Their efficacy in prevention and treatment of various microbial infections has been evaluated in numerous studies. Immune milk preparations have proven effective in prophylaxis against infections caused by a variety of gastrointestinal pathogens. Their therapeutic efficacy, however, seems more limited. A few commercial immune milk products are already on market and more applications can be expected in the coming years. This article reviews the recent progress made in isolation techniques of bovine immunoglobulins and the application of colostral and immune milk preparations in fighting various microbial infectious diseases in humans. |
format | Online Article Text |
id | pubmed-7135675 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71356752020-04-08 Milk immunoglobulins for health promotion Mehra, Raj Marnila, Pertti Korhonen, Hannu Int Dairy J Review The biological function of bovine colostral immunoglobulins is to provide the newborn calf with adequate passive immune protection against microbial infections. Immunoglobulin preparations designed for farm animals are commercially available, and some colostrum-based products are marketed also for humans as dietary supplements. The concentration of specific antibodies against a certain pathogenic microorganism can be raised in colostrum and milk by immunizing cows with this pathogen or its antigen. Advances in bioseparation and chromatographic techniques have made it possible to fractionate and enrich these antibodies and formulate so-called hyperimmune colostral or milk preparations. Their efficacy in prevention and treatment of various microbial infections has been evaluated in numerous studies. Immune milk preparations have proven effective in prophylaxis against infections caused by a variety of gastrointestinal pathogens. Their therapeutic efficacy, however, seems more limited. A few commercial immune milk products are already on market and more applications can be expected in the coming years. This article reviews the recent progress made in isolation techniques of bovine immunoglobulins and the application of colostral and immune milk preparations in fighting various microbial infectious diseases in humans. Elsevier Ltd. 2006-11 2006-08-21 /pmc/articles/PMC7135675/ /pubmed/32288340 http://dx.doi.org/10.1016/j.idairyj.2006.06.003 Text en Copyright © 2006 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Mehra, Raj Marnila, Pertti Korhonen, Hannu Milk immunoglobulins for health promotion |
title | Milk immunoglobulins for health promotion |
title_full | Milk immunoglobulins for health promotion |
title_fullStr | Milk immunoglobulins for health promotion |
title_full_unstemmed | Milk immunoglobulins for health promotion |
title_short | Milk immunoglobulins for health promotion |
title_sort | milk immunoglobulins for health promotion |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135675/ https://www.ncbi.nlm.nih.gov/pubmed/32288340 http://dx.doi.org/10.1016/j.idairyj.2006.06.003 |
work_keys_str_mv | AT mehraraj milkimmunoglobulinsforhealthpromotion AT marnilapertti milkimmunoglobulinsforhealthpromotion AT korhonenhannu milkimmunoglobulinsforhealthpromotion |